Please use this identifier to cite or link to this item:
|Title:||Clinical Application of the Food Insulin Index to Diabetes Mellitus|
|Publisher:||University of Sydney.|
School of Molecular and Microbial Bioscience.
|Abstract:||The Food Insulin Index (FII) is a novel system of ranking foods based on the insulin response in healthy subjects relative to an isoenergetic reference food. The goal of this thesis was to explore the clinical application of the FII to mealtime insulin dosing in type 1 diabetes. Carbohydrate counting is the current gold standard method for determining prandial insulin dose in type 1 diabetes, however only 7 studies assessing the efficacy of carbohydrate counting for glycaemic control in people with type 1 diabetes could be identified. Meta-analysis revealed there was no significant improvement in HbA1c with carbohydrate counting over general dietary advice and/or usual care (-0.35%, p = 0.096). This study highlighted the need for research into alternative strategies to improve the accuracy of the mealtime insulin dose. The FII reveals a notable insulin demand for foods high in protein and fat, nutrients that would normally be disregarded for mealtime insulin dosing with traditional carbohydrate counting. Compared with carbohydrate counting, the FII algorithm was able to reduce mean blood glucose level for six foods high in protein (5.7 +/- 0.2 mmol/L vs 6.5 +/- 0.2 mmol/L, p = 0.003), without significantly increasing the risk of hypoglycaemia (p = 0.155). In the first randomised, controlled trial of the real-world application of the FII, the FII was at least as good as carbohydrate counting for glycaemic control in 26 adults with type 1 diabetes (HbA1c FII: -0.1 ± 0.1% vs CC: -0.3 ± 0.2%, p = 0.855), with a trend towards reduced risk of hypoglycaemia in the FID counters after 12 weeks. Collectively, these studies offer exciting insights into the potential of the FII for optimising glycaemic control in type 1 diabetes. Until a cure can be found, the potential for clinically significant enhancements in glycaemic control offer people with diabetes greater wellbeing through a reduced burden of disease and decreased risk of long-term diabetes complications.|
|Rights and Permissions:||The author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.|
|Type of Work:||PhD Doctorate|
|Type of Publication:||Doctor of Philosophy Ph.D.|
|Appears in Collections:||Sydney Digital Theses (Open Access)|
This work is protected by Copyright. All rights reserved. Access to this work is provided for the purposes of personal research and study. Except where permitted under the Copyright Act 1968, this work must not be copied or communicated to others without the express permission of the copyright owner. Use the persistent URI in this record to enable others to access this work.
|Bell_KJ_thesis_1.pdf||PhD Thesis||41.59 MB||Adobe PDF||View/Open|
|Bell_KJ_thesis_2.pdf||PhD Thesis||7.04 MB||Adobe PDF||View/Open|
Items in Sydney eScholarship Repository are protected by copyright, with all rights reserved, unless otherwise indicated.